Email Updates

You are here

Home»Media

AVAC in the News

  • UNAIDS: Sharp drop in new infections

    The latest Global Report on HIV/AIDS says the number of new infections continues to fall, with the sharpest declines in the Caribbean and sub-Saharan Africa.

    November 20, 2012
    Voice of America

  • Good Participatory Practice TB drug trial guidelines lay groundwork for research, use of new treatments

    If you consider all the years that time stood still in the world of tuberculosis drug research, the most compelling aspect of the Good Participatory Practice Guidelines for TB Drug Trials just released by a Critical Paths to TB Drug Regimens working group is that occasions exist for them to be used.

    October 10, 2012
    Science Speaks

  • An invisible issue: The presidential campaign and HIV/AIDS

    This campaign season, the fight against HIV/AIDS has been absent from the press materials released by both President Obama and Governor Romney — as well as from the conversation.

    October 8, 2012
    Global Post

  • Male circumcision benefits women too

    The benefits of medical male circumcision have been proven to also extend to women. It has been shown that female partners of men who are circumcised have a less risk of contracting the Human Papilloma Virus (HPV), a sexually transmitted virus that causes cervical cancer.

    October 8, 2012
    Voluntary Medical Male Circumcision
    health-e

  • Are we on the verge of an AIDS breakthrough?

    Tremendous progress has been made against HIV/AIDS in the developing world. But where does the fight now stand and are we on the verge of a breakthrough?

    September 27, 2012
    HuffPost Live

  • Light shines at the end of the HIV tunnel

    We are at a time of great promise in the fight against AIDS. A few weeks ago at the International AIDS Conference in Washington, in the United States, the buzz was all about "ending AIDS". And it was not just hype.

    September 14, 2012
    Mail & Guardian (South Africa)

  • Gilead pill can prevent HIV in heterosexuals, CDC guidelines say

    Gilead Sciences’ anti-AIDS pill Truvada safely and effectively reduces the risk of HIV for healthy people having sexual intercourse, according to the first US Centers for Disease Control and Prevention guidelines on using the drugs for prevention in heterosexuals.

    August 9, 2012
    PrEP
    Bloomberg News

  • Renew commitment to male circumcision

    We have made great strides in the fight against HIV in the past decade. HIV treatment has saved millions of lives around the world and fewer people are becoming infected with HIV. But to continue to reduce new infections, we must use every option available.

    August 6, 2012
    Voluntary Medical Male Circumcision
    New Vision

  • PrEP approved, insurance coverage unclear

    Weeks after federal approval of the first drug for HIV prevention, health advocates are divided over what the next step should be and it is unclear whether access to the expensive pills will be paid for by government programs and private insurers.

    August 1, 2012
    PrEP
    Gay City News

  • Circumcision advocate tackles the cringe factor to fight AIDS

    The studies are clear: Circumcising heterosexual men reduces their infection rate by at least 60 percent and some studies show it’s by 65 percent or more.

    July 26, 2012
    Voluntary Medical Male Circumcision
    NBC News

Pages